ABOUT THIS STUDY
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting the study website. Please see the references below:
Pfizer Clinical Trials Contact Center
1-800-718-1021
- Subjects who were recently diagnosed with both hypertension and dyslipidemia and who are not yet taking any medications for these conditions OR subjects with both hypertension and dyslipidemia who were previously treated with antihypertensive and/or lipid lowering medications but discontinued these medications for at least 3 months prior to the Screening visit.
- SBP 140-169 mmHg and/or DBP 90-105 mmHg, LDL-C 110-160 mg/dL
- Subjects with a history of MI, angina, coronary artery bypass or intra-coronary
interventions, stroke, TIA, CHF or cardiomyopathy requiring treatment.
- Subjects with a known history of Type I or Type 2 Diabetes Mellitus or a fasting blood
glucose > 126 mg/dL at the Screening visit.
NEED INFO?
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Jonesboro, Arkansas
- Little Rock, Arkansas
- Garden Grove, California
- Long Beach, California
- Tustin, California
- Aventura, Florida
- Ft. Lauderdale, Florida
- Miami, Florida
- Pembroke Pines, Florida
- Atlanta, Georgia
- Decatur, Georgia
- Bossier City, Louisiana
- Fair Haven, Michigan
- Livonia, Michigan
- Jackson, Mississippi
- Jackson, Mississippi
- Excelsior Springs, Missouri
- Berlin, New Jersey
- Elizabeth, New Jersey
- Princeton, New Jersey
- South Bound Brook, New Jersey
- Binghamton, New York
- Monroe, North Carolina
- Winston-Salem, North Carolina
- Cincinnati, Ohio
- Dayton, Ohio
- Eugene, Oregon
- Bensalem, Pennsylvania
- Kingsport, Tennessee
- Beaumont, Texas
- Colleyville, Texas
- Houston, Texas
- Temple, Texas
- Norfolk, Virginia
- Calgary, Alberta
- Calgary, Alberta
- Calgary, Alberta
- Calgary, Alberta
- Calgary, Alberta
- Red Deer, Alberta
- Campbell River, British Columbia
- Chilliwack, British Columbia
- New Westminster, British Columbia
- North Vancouver, British Columbia
- Quesnel, British Columbia
- Vancouver, British Columbia
- Vancouver, British Columbia
- Vancouver, British Columbia
- Vancouver, British Columbia
- Vancouver, British Columbia
- Winnipeg, Manitoba
- Winnipeg, Manitoba
- Antigonish, Nova Scotia
- Digby, Nova Scotia
- Halifax, Nova Scotia
- Halifax, Nova Scotia
- Truro, Nova Scotia
- Wolfville, Nova Scotia
- Alymer, Ontario
- Corunna, Ontario
- Exeter, Ontario
- Hamilton, Ontario
- Kingston, Ontario
- London, Ontario
- London, Ontario
- London, Ontario
- London, Ontario
- London, Ontario
- London, Ontario
- London, Ontario
- North York, Ontario
- North York, Ontario
- Oshawa, Ontario
- Oshawa, Ontario
- Peterborough, Ontario
- Sarnia, Ontario
- Toronto, Ontario
- Toronto, Ontario
- Toronto, Ontario
- Toronto, Ontario
- Waterloo, Ontario
- Weston, Ontario
- Whitby, Ontario
- Charlottetown, Prince Edward Island
- Bonaventure, Quebec
- Chomedy, Quebec
- Gatineau, Quebec
- Granby, Quebec
- Longueuil, Quebec
- Montreal, Quebec
- Montreal, Quebec
- Pointe-Claire, Quebec
- Sherbrooke, Quebec
- St Jerome, Quebec
- St-Georges Ouest, Quebec
- St-Marc Des Carrieres, Quebec
- St. Lambert, Quebec
- Ste-foy, Quebec
- Regina, Saskatchewan
- Quebec,
- Quebec,
- Quebec,
- Rimouski,
- St-Gedeon Beauce,
- St. John's,
- St. John's,
- St. John's,
- Ayr, Ayrshire
- Sandy, Bedfordshire
- Peterborough, Cambs
- Thornhill, Cardiff
- Fowey, Cornwall
- Darlington, County Durham
- Darlington, County Durham
- Paignton, Devon
- Plymouth, Devon
- Bournemouth, Dorset
- Angus, Dundee
- Central Milton Keyne, England
- Lancaster, England
- Surrey, England
- Wishaw, Lanarkshire, England
- Leigh-on-sea, Essex
- nEWPORT, gWENT
- Letchworth, Hertfordshire
- Canterbury, Kent
- Whitstable, Kent
- Blackpool, Lancashire
- Spalding, Lincolnshire
- Bangor, Belfast, Northern Ireland
- Coatbridge, Scotland
- Glasgow, Scotland
- Frome, Somerset
- Stairfoot, Barnsley, South Yorkshire
- Weybridge, Surrey
- Leeds, West Yorkshire
- Sheffield, Yorkshire
- Aberdeen,
- Berkshire,
- Cambridge,
- Canterbury,
- Coventry,
- Coventry,
- Dorking,
- Dundee,
- Glasgow,
- Glasgow,
- Glasgow,
- Hertfordshire,
- Kent,
- Leeds,
- Newcastle-upon-Tyne,
- Newcastle-upon-Tyne,
- Nottingham,
- Rochdale,
- Shrewsbury,
- Stourbridge,
- Swanley,
- Swindon,
- Birmingham, Alabama
- Birmingham, Alabama
- Huntsville, Alabama
- Little Rock, Arkansas
- Los Angeles, California
- Oakland, California
- Pico Rivera, California
- Bridgeport, Connecticut
- Washington, District of Columbia
- Washington, District of Columbia
- Aventura, Florida
- Gainesville, Florida
- Jacksonville, Florida
- Orlando, Florida
- Pensacola, Florida
- Vero Beach, Florida
- Athens, Georgia
- Atlanta, Georgia
- Atlanta, Georgia
- Atlanta, Georgia
- Atlanta, Georgia
- Augusta, Georgia
- Columbus, Georgia
- Columbus, Georgia
- Decatur, Georgia
- Lincolnton, Georgia
- Savannah, Georgia
- Chicago, Illinois
- Chicago, Illinois
- Maywood, Illinois
- Merrillville, Indiana
- Overland Park, Kansas
- Bossier City, Louisiana
- New Orleans, Louisiana
- New Orleans, Louisiana
- Shreveport, Louisiana
- Shreveport, Louisiana
- Baltimore, Maryland
- Baltimore, Maryland
- Columbia, Maryland
- Randallstown, Maryland
- Rockville, Maryland
- Westminster, Maryland
- Brockton, Massachusetts
- Wellesley Hills, Massachusetts
- Detroit, Michigan
- Detroit, Michigan
- Lansing, Michigan
- Livonia, Michigan
- Jackson, Mississippi
- Jackson, Mississippi
- Kansas City, Missouri
- Kansas City, Missouri
- St. Louis, Missouri
- St. Louis, Missouri
- St. Louis, Missouri
- Cherry Hill, New Jersey
- East Orange, New Jersey
- Elizabeth, New Jersey
- Hammonton, New Jersey
- South Bound Brook, New Jersey
- Voorhees, New Jersey
- Woodbury, New Jersey
- Brooklyn, New York
- Brooklyn, New York
- Buffalo, New York
- Mineola, New York
- Charlotte, North Carolina
- Greenville, North Carolina
- Monroe, North Carolina
- Monroe, North Carolina
- Winston-Salem, North Carolina
- Winston-Salem, North Carolina
- Cincinnati, Ohio
- Cincinnati, Ohio
- Cincinnati, Ohio
- Cincinnati, Ohio
- Dayton, Ohio
- Dayton, Ohio
- Maumee, Ohio
- Perrysburg, Ohio
- Bensalem, Pennsylvania
- Philadelphia, Pennsylvania
- Philadelphia, Pennsylvania
- Philadelphia, Pennsylvania
- Bamberg, South Carolina
- Charleston, South Carolina
- Clinton, South Carolina
- Mt. Pleasant, South Carolina
- Simpsonville, South Carolina
- Bartlett, Tennessee
- Jackson, Tennessee
- Beaumont, Texas
- Dallas, Texas
- Dallas, Texas
- Houston, Texas
- Houston, Texas
- Houston, Texas
- Emporia, Virginia
- Norfolk, Virginia
- Norfolk, Virginia
- Richmond, Virginia
- Richmond, Virginia
- Viginia Beach, Virginia
- Virginia Beach, Virginia
- Milwaukee, Wisconsin
Descriptive Information | ||||
---|---|---|---|---|
Brief Title ICMJE | Caduet in an Untreated Subject Population | |||
Official Title ICMJE | An 8-Week Randomized, Double-Blind, Placebo-Controlled Trial Examining The Efficacy And Safety Of Caduet® In Simultaneously Achieving Blood Pressure And Lipid Goals In An Untreated Hypertensive And Dyslipidemic Subject Population. (CUSP - Caduet in Untreated Subject Population) | |||
Brief Summary | The purpose of this study is to determine if Caduet will lower blood pressure to <140/90 mmHg and lower LDL Cholesterol to <100 mg/dL in subjects with hypertension and dyslipidemia who are not currently being treated for these medical conditions. | |||
Detailed Description | Not Provided | |||
Study Type ICMJE | Interventional | |||
Study Phase ICMJE | Phase 4 | |||
Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Primary Purpose: Treatment | |||
Condition ICMJE |
| |||
Intervention ICMJE | Drug: Caduet | |||
Study Arms ICMJE | Not Provided | |||
Publications * | Not Provided | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. | ||||
Recruitment Information | ||||
Recruitment Status ICMJE | Completed | |||
Enrollment ICMJE | 220 | |||
Original Enrollment ICMJE | Same as current | |||
Actual Study Completion Date ICMJE | September 2007 | |||
Primary Completion Date | Not Provided | |||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
| |||
Sex/Gender ICMJE |
| |||
Ages ICMJE | 21 Years and older (Adult, Older Adult) | |||
Accepts Healthy Volunteers ICMJE | No | |||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries ICMJE | United States | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number ICMJE | NCT00332761 | |||
Other Study ID Numbers ICMJE | A3841046 | |||
Has Data Monitoring Committee | Not Provided | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement ICMJE | Not Provided | |||
Responsible Party | Not Provided | |||
Study Sponsor ICMJE | Pfizer | |||
Collaborators ICMJE | Not Provided | |||
Investigators ICMJE |
| |||
PRS Account | Pfizer | |||
Verification Date | August 2008 | |||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |